Breast Atypical Lobular Hyperplasia

subtype

Identifier: CI-CAN-00000593
Entity page: /cancer/breast-atypical-lobular-hyperplasia ↗
Edges: 15

Neighbours: 4 drugs11 trials
Drawn: 15 of 15 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Breast Atypical Lobular Hyperplasia investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Tamoxifensmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Breast Atypical Lobular Hyperplasia	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Bexarotenesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Breast Atypical Lobular Hyperplasia studied in …STUDIED_INderived11 of 11show fewer
→ studied in	NCT04570956Phase 2 · terminated Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT06184750Phase 2 · recruiting Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05178498recruiting Impact of Dietary Inflammatory Potential on Breast Cancer Risk · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05755269terminated Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT02928978Phase 2 · completed Ruxolitinib for Premalignant Breast Disease · condition mapped ALIAS · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT07499999Phase 2 · not yet recruiting Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer · condition mapped ALIAS · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT03868475NA · withdrawn Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions · condition mapped ALIAS · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT05868252unknown Molecular Analysis of the Sloane Project · condition mapped ALIAS · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT03323658Phase 1 · completed Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT00620087NA · completed Molecular Breast Imaging in Women With Atypia and LCIS · condition mapped ALIAS · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT01874184NA · completed Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer · condition mapped ALIAS · 11 trials mapped (3 active)	—	—	Breast Atypical Lobular Hyperplasia	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains